In a study by Pan et al., the authors reduced proliferative and invasive activities in the U251 lineage of GBM, through the induction of inhibition of AKT, PCNA, CyclinD1, and MMP-2, via miR-149 [29]. Here, MMP2 is linked to glioblastoma.